Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression
Therapeutic Advances in Psychopharmacology 2020 Marcos Gómez-Revuelta, María Fernández-Rodríguez, Laura Boada-Antón et al.
Ketamine’s pharmacological profile makes it an interesting and useful drug to challenge treatment-resistant-depression (TRD). Emerging adverse events associated with single-slow-sub-anaesthetic doses for the treatment of depression are common, although generally transient and self-limited. Nevertheless, data on the safety of this practice are scarce. Thus, it seems timely before ketamine is...